GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
Clinical trial NCT00085020 · COMPLETED
Trial details
- NCT number
- NCT00085020
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2004-12-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.